OptimizeRX Corp (NASDAQ: OPRX) stock closed at $13.56 on 3/12/24 after a major decline of -14.1%. Moreover, trading volume in this decline was exceptionally high at 360% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -15.9% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, OPRX is expected to continue to be a modest Value Eraser.
OptimizeRX has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. OptimizeRX has a very low Appreciation Score of 10 but a good Power Rating of 75, and the Negative Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment